Average Cholesterol Levels By Age Chart

But the drug’s future is under a cloud due to challenges to the U. S. patent that Astra Zeneca will defend at trial later this month.

Wider approval for Crestor is likely to boost sales of the drug but industry analysts say the size of the opportunity is uncertain because of the looming arrival of cheaper generic versions of Pfizer Inc’s PFE. Average Cholesterol Levels By Age Chart astra Zeneca’s global sales of Crestor totaled $4.5 billion in 2009. Thomson Pharma consensus forecasts point to sales of $6.5 billion in 2013 when it will be the Anglo-Swedish company’s biggest seller by far. Crestor is a main driver for the company as sales of older medicines fall away.

Crestor compared with 2.8 percent with a placebo the FDA said. An FDA advisory panel that reviewed the Jupiter results in December backed wider use but voiced concern that doctors might use Crestor too broadly in patients with low risk. On Monday the FDA said doctors “must interpret the results of the Jupiter trial with caution.” The findings “do not support the use of Crestor in all patients with Average Cholesterol Levels By Age Chart elevated CRP” the agency said. For example there was no evidence Crestor helped patients with high CRP but no traditional risk factors such as high blood pressure low HDL or “good” cholesterol smoking or a family history of early heart disease the FDA said.

On Monday the FDA said doctors “must interpret the results of the Jupiter trial with caution.” The findings “do not support the use of Crestor in all patients with elevated CRP” the agency said. For example there was no evidence Crestor helped patients with high CRP but no traditional risk factors such as high blood pressure low HDL or “good” cholesterol smoking or a family history of early heart disease the FDA said. Wider approval for Crestor is likely to boost sales of the drug but industry analysts say the size of the opportunity is uncertain because of the looming arrival of cheaper generic versions of Pfizer Inc’s PFE.

The study tested Crestor versus a placebo in middle-aged people with healthy cholesterol but high CRP. The rate of major cardiovascular problems was 1.6 percent for patients treated with Crestor compared with 2.8 percent with a placebo the FDA said. An FDA advisory panel that reviewed the Jupiter results in December backed wider use but voiced concern that doctors might use Crestor too broadly in patients with low risk.

The approval was based on data from a nearly 18000-patient study funded by Astra Zeneca and called Jupiter. The study tested Crestor versus a placebo in middle-aged people with healthy cholesterol but high CRP. The rate of major cardiovascular problems was 1.6 percent for patients treated with Crestor compared with 2.8 percent with a placebo the FDA said.

An FDA advisory panel that reviewed the Jupiter results in December backed wider use but voiced concern that doctors might use Crestor too broadly in patients with low risk. On Monday the FDA said doctors “must interpret the results of the Jupiter trial with

Average Cholesterol Levels By Age Chart

caution.

UPDATE 2-U. S. clears wider use of Astra Zeneca cholesterol drug The Food and Drug Administration cleared Crestor for a group of people numbering in the millions who are not typically prescribed cholesterol drugs
Average Cholesterol Levels By Age Chart
now. Crestor won FDA approval for reducing the risk of heart attacks strokes bypass operations and artery-clearing procedures in people with high levels of C-reactive protein CRP plus at least one other risk factor.

Both Crestor and Lipitor are part of the family of cholesterol-lowering drugs called statins that are already prescribed to millions of people. Statins typically are prescribed to lower high cholesterol a risk factor for heart disease which remains the leading killer in the United States. But more than half of patients who suffer heart attacks or other cardiovascular problems have normal cholesterol levels. That led Astra Zeneca to search for other groups that could benefit from Crestor. Complications in the Jupiter study were similar to known risks of statins and included muscle pain the FDA said.

Both Crestor and Lipitor are part of the family of cholesterol-lowering drugs called statins that are already prescribed to millions of people. Statins typically are prescribed to lower high cholesterol a risk factor for heart disease which remains the leading Average Cholesterol Levels By Age Chart killer in the United States –

  • Astra Zeneca will defend at trial later this month
  • S
  • The approval was based on data from a nearly 18000-patient study funded by Astra Zeneca and called Jupiter
  • That led Astra Zeneca to search for other groups that could benefit from Crestor
  • An FDA advisory panel that reviewed the Jupiter results in December backed wider use but voiced concern that doctors might use Crestor too broadly in patients with low risk
  • Statins typically are prescribed to lower high cholesterol a risk factor for heart disease which remains the leading killer in the United States

. But more than half of patients who suffer Average Cholesterol Levels By Age Chart heart attacks or other cardiovascular problems have normal cholesterol levels.

On Monday the FDA said doctors “must interpret the results of the Average Cholesterol Levels By Age Chart Jupiter trial with caution.” The findings “do not support the use of Crestor in all patients with elevated CRP” the agency said. For example there was no evidence Crestor helped patients with high CRP but no Average Cholesterol Levels By Age Chart traditional risk factors such as high blood pressure low HDL or “good” cholesterol smoking or a family history of early heart disease the FDA said. Wider approval for Crestor is likely to boost sales of the drug but industry analysts say the size of the opportunity is uncertain because of the looming arrival of cheaper generic versions of Pfizer Inc’s PFE.

Wider approval for Crestor is likely to boost sales of the drug but industry analysts say the size of the opportunity is uncertain because of the looming arrival of cheaper generic versions of Pfizer Inc’s PFE. Astra Zeneca’s global sales of Crestor totaled $4.5 billion in 2009. Thomson Pharma consensus forecasts point to sales of $6.5 billion in 2013 when it will be the Anglo-Swedish company’s biggest seller by far. Crestor is a main
Average Cholesterol Levels By Age Chart
driver for the company as sales of older medicines fall away.

http://depthtml.musc.edu/catalyst/2004/co5-21cholesterol.htm
http://loweringcholesteroltips.info/easy-high-cholesterol-solutions-reviews-in-paxico/
http://loweringcholesteroltips.info/simplest-high-cholesterol-level-natural-cure-reviews-in-arriba/
http://www.tamiu.edu/newsinfo/3-17-97/articl12.htm

Tags: , , , <BR/>
Average Cholesterol Levels By Age Chart 3.5 out of 5 based on 73 ratings.
 

Leave a Reply

You must be logged in to post a comment.